​

Immunome (IMNM) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChart

Immunome Revenue Highlights

Latest Revenue (Y)

$9.04M

0

Immunome Revenue by Period

Immunome Revenue by Year

DateRevenueChange
2024-12-31$9.04M-35.50%
2023-12-31$14.02M100.00%
2022-12-31-100.00%
2021-12-31-100.00%
2020-12-31-100.00%
2019-12-31-100.00%
2018-12-31--

Immunome generated $9.04M in revenue during NA 2024, up -35.50% compared to the previous quarter, and up Infinity% compared to the same period a year ago.

Immunome Revenue by Quarter

DateRevenueChange
2025-09-30--100.00%
2025-06-30$4.01M37.22%
2025-03-31$2.93M6.87%
2024-12-31$2.74M-5.91%
2024-09-30$2.91M23.10%
2024-06-30$2.36M129.74%
2024-03-31$1.03M-73.11%
2023-12-31$3.83M7.32%
2023-09-30$3.56M-16.37%
2023-06-30$4.26M80.33%
2023-03-31$2.36M100.00%
2022-12-31-100.00%
2022-09-30-100.00%
2022-06-30-100.00%
2022-03-31-100.00%
2021-12-31-100.00%
2021-09-30-100.00%
2021-06-30-100.00%
2021-03-31-100.00%
2020-12-31-100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31-100.00%
2019-12-31-100.00%
2019-09-30-100.00%
2019-06-30-100.00%
2019-03-31--

Immunome generated - in revenue during Q3 2025, up -100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Immunome Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
MAZEMaze Therapeutics$167.50M-
ABCLAbCellera Biologics$28.83M$8.96M
IMNMImmunome$9.04M-
CLDXCelldex Therapeutics$7.02M-
ZBIOZenas BioPharma$5.00M-
UPBUpstream Bio$2.37M$683.00K
NTLAIntellia Therapeutics-$13.78M
PHVSPharvaris--
SYRESpyre Therapeutics--
VERAVera Therapeutics--
BHVNBiohaven--

IMNM Revenue FAQ

What is Immunome’s yearly revenue?

Immunome's yearly revenue for 2024 was $9.04M, representing a decrease of -35.50% compared to 2023. The company's yearly revenue for 2023 was $14.02M, representing an increase of 100.00% compared to 2022. IMNM's yearly revenue for 2022 was $0, representing an increase of 100.00% compared to 2021.

What is Immunome’s quarterly revenue?

Immunome's quarterly revenue for Q3 2025 was $0, a -100.00% decrease from the previous quarter (Q2 2025), and a -100.00% decrease year-over-year (Q3 2024). The company's quarterly revenue for Q2 2025 was $4.02M, a 37.22% increase from the previous quarter (Q1 2025), and a 69.84% increase year-over-year (Q2 2024). IMNM's quarterly revenue for Q1 2025 was $2.93M, a 6.87% increase from the previous quarter (Q4 2024), and a 184.35% increase year-over-year (Q1 2024).

What is Immunome’s revenue growth rate?

Immunome's revenue growth rate for the last 3 years (2022-2024) was 0%, and for the last 5 years (2020-2024) was 0%.